Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.
Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
Read Also
- Top Ministers meet with packaged food industry, discuss issues around ease of doing business, taxation
- 25% of Indian key reservoirs full as overall storage up at 87% of capacity
- Boeing could lose billions if the strike doesn’t end soon
- Hackers demand insane ransom from SeaTac Airport
- An inside look at how the Bank of Canada makes its interest rate decisions
- Hawkish Bank of England? Don’t be so sure.
- Fed rate cut forecasts show massive change from early summer optimism
- FATF urges India to accelerate prosecutions in financial fraud cases, placing India in ‘regular follow-up’ category
- Royal Caribbean quietly updates its banned items list
- Piyush Goyal meets shipping & cargo cos to address issues, bring down shipping costs
Latest MarketBeat
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
- Stocks to Take Advantage of Rising Gold Prices
- Smartsheet Is a Smart Buy for Traders and Investors: Here's Why
- 2 Avocado Stocks Proving the Superfood Can Be a Super Investment
- Trucking Stocks Rebound: Big Rigs, Bigger Opportunity
- Johnson Controls: AI Sleeper Stock Set to Cool Data Centers
- Maximize Gains: Invest in AST SpaceMobile’s 5G Breakthrough
- e.l.f. Beauty: The High-Growth Stock You Shouldn't Ignore
- Boeing's Setback Could Be Investors’ Big Opportunity: Here's Why
- What the Bulls and Bears Are Saying About NVIDIA Stock